This offer is only addressed to countries/markets not covered by patent rights in force
Products with dossier ready & registered in EU
Lenalidomide
Form: capsules
Strenghts: 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg
Field: oncology
Mechanism of action: immunomodulator
Indication: multiple myeloma
Patent expiry: March 2022